Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2019
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
Robert F Cornell, Bonnie Ky, Brendan M Weiss, et al.
The Journal of Clinical Investigation
|
March 22, 2019
B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma
Adam D Cohen, Alfred L Garfall, Edward A Stadtmauer, et al.
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target
Zhiwei Ang, Annette Castro, Luca Paruzzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2014
Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells
Aaron P Rapoport, Nicole A Aqui, Edward A Stadtmauer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 1, 2021
Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Dynamics Tracking
Hui Chen, Zhao Li, Sheng Feng, et al.
Blood
|
October 30, 2010
Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma
Aaron P Rapoport, Nicole A Aqui, Edward A Stadtmauer, et al.
Blood
|
September 14, 2021
A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma
Muzaffar H Qazilbash, Neeraj Y Saini, Soung-Chul Cha, et al.
Blood
|
June 22, 2011
Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis
Shaji Kumar, Mei-Jie Zhang, Peigang Li, et al.
Science Immunology
|
April 19, 2017
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
Thomas Condamine, George A Dominguez, Je-In Youn, et al.
Transplantation and Cellular Therapy
|
June 16, 2026
Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival
Gurbakhash Kaur, Jennifer Logue, Ruta Brazauskas, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2019
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
Robert F Cornell, Bonnie Ky, Brendan M Weiss, et al.
The Journal of Clinical Investigation
|
March 22, 2019
B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma
Adam D Cohen, Alfred L Garfall, Edward A Stadtmauer, et al.
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target
Zhiwei Ang, Annette Castro, Luca Paruzzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2014
Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells
Aaron P Rapoport, Nicole A Aqui, Edward A Stadtmauer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 1, 2021
Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Dynamics Tracking
Hui Chen, Zhao Li, Sheng Feng, et al.
Blood
|
October 30, 2010
Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma
Aaron P Rapoport, Nicole A Aqui, Edward A Stadtmauer, et al.
Blood
|
September 14, 2021
A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma
Muzaffar H Qazilbash, Neeraj Y Saini, Soung-Chul Cha, et al.
Blood
|
June 22, 2011
Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis
Shaji Kumar, Mei-Jie Zhang, Peigang Li, et al.
Science Immunology
|
April 19, 2017
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
Thomas Condamine, George A Dominguez, Je-In Youn, et al.
Transplantation and Cellular Therapy
|
June 16, 2026
Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival
Gurbakhash Kaur, Jennifer Logue, Ruta Brazauskas, et al.
Page
of 8